Subheading

Risk Evaluation & Mitigation Strategies (REMS)

Schedule A Consultation

Custom-tailored solutions for every client's unique needs

Proven REMS Audit Services

Compliance Architects® is a proven partner in REMS audit services, delivering custom-tailored solutions to fit each client. Our agile approach is designed to meet the complexity, requirements, and multi-party involvement of REMS audits — and we’ve demonstrated consistent success in helping sponsors remain compliant.

FDA’s approach to evaluating risk management and compliance

Understanding REMS Requirements

FDA conducts inspections to evaluate compliance with risk evaluation and mitigation strategies (REMS) requirements, ensuring that a drug’s benefits outweigh its risks. Because these inspections are prioritized using a risk-based approach, REMS audits differ significantly from “typical” site audits and demand specialized expertise.

The REMS process often includes:

Enforcement actions and their impact on your product

The Consequences of Noncompliance

Compliance Architects® is a proven partner in REMS audit services, delivering custom-tailored solutions to fit each client. Our agile approach is designed to meet the complexity, requirements, and multi-party involvement of REMS audits — and we’ve demonstrated consistent success in helping sponsors remain compliant.

From concept to market, managed right

Comprehensive Project Management for Seamless Commercialization

Successful commercialization requires more than meeting regulator requirements and expectations alone. We provide end-to-end project management support to ensure your products are advanced from concept to market. By partnering with us, your team benefits from experienced project managers, regulatory experts, and commercialization operators who oversee every facet of the commercialization process, ensuring it stays on track and in alignment with your business expectations.

Our commercialization project management services include:

Trusted expertise for faster success

Why Choose Compliance Architects?

The FDA will take enforcement action if issues found during REMS inspections are not promptly corrected. Failure to comply may result in product seizure, injunctions, civil penalties, or warning letters. FDA also reviews REMS assessment reports to evaluate ongoing compliance and may issue regulatory actions to mitigate serious patient safety risks.

Heading

CTA BLURB

Please fill out the form below

Contact our team today